Knockdown of lncRNA PVT1 repressed tumor progression via targeting JAK2/STAT3/PD-L1 in cisplatin-resistant ovarian cancer cells (Chen et al., 2021). This evidence concerns the gene STAT3 and ovarian carcinoma.